1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 GLU 82 - PHE 83 MODEL 5 OMEGA =211.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION GLU 82 - PHE 83 MODEL 11 OMEGA =210.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION GLU 82 - PHE 83 MODEL 12 OMEGA =210.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION Ullner, M. Selander, M. Persson, E. Stenflo, J. Drakenberg, T. Teleman, O. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking H O -1 17.007 HYDROXIDE ION non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 31 5974 5983 10.1021/bi00141a004 1627540 Three-dimensional structure of the apo form of the N-terminal EGF-like module of blood coagulation factor X as determined by NMR spectroscopy and simulated folding. 1992 US Biochemistry BICHAW 0033 0006-2960 29 8111 1H NMR Assignment and Secondary Structure of the Ca2+-Free Form of the Amino-Terminal Epidermal Growth Factor Like Domain in Coagulation Factor X 1990 US J.Biol.Chem. JBCHA3 0071 0021-9258 264 16897 Calcium Binding to the Isolated Beta-Hydroxyaspartic Acid-Containing Epidermal Growth Factor-Like Domain of Bovine Factor X 1989 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 4560.949 EGF-LIKE MODULE OF BLOOD COAGULATION FACTOR X 1 man polymer 17.007 HYDROXIDE ION 1 syn non-polymer no no KDGDQCEGHPCLNQGHCKDGIGDYTCTCAEGFEGKNCEFSTR KDGDQCEGHPCLNQGHCKDGIGDYTCTCAEGFEGKNCEFSTR A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n cattle Bos sample 9913 Bos taurus pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conf repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1994-01-31 1 1 2008-03-24 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1992-04-21 REL OH HYDROXIDE ION 13 OH 63 2 OH OH 87 A LYS 45 n 1 LYS 45 A ASP 46 n 2 ASP 46 A GLY 47 n 3 GLY 47 A ASP 48 n 4 ASP 48 A GLN 49 n 5 GLN 49 A CYS 50 n 6 CYS 50 A GLU 51 n 7 GLU 51 A GLY 52 n 8 GLY 52 A HIS 53 n 9 HIS 53 A PRO 54 n 10 PRO 54 A CYS 55 n 11 CYS 55 A LEU 56 n 12 LEU 56 A ASN 57 n 13 ASN 57 A GLN 58 n 14 GLN 58 A GLY 59 n 15 GLY 59 A HIS 60 n 16 HIS 60 A CYS 61 n 17 CYS 61 A LYS 62 n 18 LYS 62 A ASP 63 n 19 ASP 63 A GLY 64 n 20 GLY 64 A ILE 65 n 21 ILE 65 A GLY 66 n 22 GLY 66 A ASP 67 n 23 ASP 67 A TYR 68 n 24 TYR 68 A THR 69 n 25 THR 69 A CYS 70 n 26 CYS 70 A THR 71 n 27 THR 71 A CYS 72 n 28 CYS 72 A ALA 73 n 29 ALA 73 A GLU 74 n 30 GLU 74 A GLY 75 n 31 GLY 75 A PHE 76 n 32 PHE 76 A GLU 77 n 33 GLU 77 A GLY 78 n 34 GLY 78 A LYS 79 n 35 LYS 79 A ASN 80 n 36 ASN 80 A CYS 81 n 37 CYS 81 A GLU 82 n 38 GLU 82 A PHE 83 n 39 PHE 83 A SER 84 n 40 SER 84 A THR 85 n 41 THR 85 A ARG 86 n 42 ARG 86 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 A A HG3 HE1 GLU PHE 77 83 0.92 1 A A CG HE1 GLU PHE 77 83 1.19 1 A A HG3 CE1 GLU PHE 77 83 1.20 1 A A CB HE1 GLU PHE 77 83 1.52 1 A A CG CE1 GLU PHE 77 83 2.09 3 A A O H LEU GLY 56 59 1.56 5 A A HG3 HE1 GLU PHE 77 83 1.23 5 A A O N GLU GLU 77 82 2.13 9 A A O O LYS OH 62 87 2.19 10 A A HG3 HE1 GLU PHE 77 83 1.03 10 A A CG HE1 GLU PHE 77 83 1.47 10 A A HG3 CE1 GLU PHE 77 83 1.50 10 A A H O GLU PHE 77 83 1.58 11 A A HG3 HE1 GLU PHE 77 83 1.04 11 A A CG HE1 GLU PHE 77 83 1.37 11 A A HG3 CE1 GLU PHE 77 83 1.44 12 A A HG3 HE1 GLU PHE 77 83 0.91 12 A A CG HE1 GLU PHE 77 83 1.27 12 A A HG3 CE1 GLU PHE 77 83 1.30 12 A A O N ASP CYS 48 50 2.17 12 A A CG CE1 GLU PHE 77 83 2.18 1 A LYS 45 10.17 4 A LYS 45 10.05 5 A A GLU PHE 82 83 -148.03 11 A A GLU PHE 82 83 -149.73 12 A A GLU PHE 82 83 -149.55 1 A HIS 53 0.138 SIDE CHAIN 1 A HIS 60 0.176 SIDE CHAIN 1 A TYR 68 0.090 SIDE CHAIN 1 A PHE 83 0.325 SIDE CHAIN 2 A HIS 53 0.155 SIDE CHAIN 2 A HIS 60 0.107 SIDE CHAIN 2 A TYR 68 0.109 SIDE CHAIN 3 A HIS 53 0.124 SIDE CHAIN 3 A HIS 60 0.178 SIDE CHAIN 3 A TYR 68 0.132 SIDE CHAIN 4 A HIS 53 0.162 SIDE CHAIN 4 A HIS 60 0.170 SIDE CHAIN 4 A TYR 68 0.108 SIDE CHAIN 5 A HIS 53 0.166 SIDE CHAIN 5 A HIS 60 0.158 SIDE CHAIN 5 A TYR 68 0.107 SIDE CHAIN 5 A PHE 83 0.320 SIDE CHAIN 6 A HIS 53 0.158 SIDE CHAIN 6 A HIS 60 0.177 SIDE CHAIN 6 A TYR 68 0.075 SIDE CHAIN 7 A HIS 53 0.154 SIDE CHAIN 7 A HIS 60 0.152 SIDE CHAIN 7 A TYR 68 0.098 SIDE CHAIN 8 A HIS 53 0.159 SIDE CHAIN 8 A HIS 60 0.157 SIDE CHAIN 8 A TYR 68 0.109 SIDE CHAIN 9 A HIS 53 0.174 SIDE CHAIN 9 A HIS 60 0.157 SIDE CHAIN 9 A TYR 68 0.112 SIDE CHAIN 10 A HIS 53 0.172 SIDE CHAIN 10 A HIS 60 0.165 SIDE CHAIN 10 A TYR 68 0.110 SIDE CHAIN 10 A PHE 76 0.078 SIDE CHAIN 10 A PHE 83 0.300 SIDE CHAIN 11 A HIS 53 0.160 SIDE CHAIN 11 A HIS 60 0.140 SIDE CHAIN 11 A TYR 68 0.062 SIDE CHAIN 11 A PHE 83 0.316 SIDE CHAIN 12 A HIS 53 0.166 SIDE CHAIN 12 A HIS 60 0.165 SIDE CHAIN 12 A TYR 68 0.086 SIDE CHAIN 12 A PHE 83 0.320 SIDE CHAIN 13 A HIS 53 0.156 SIDE CHAIN 13 A HIS 60 0.157 SIDE CHAIN 13 A TYR 68 0.143 SIDE CHAIN 1 8.57 1.40 108.80 117.37 A A A ND1 CG CD2 HIS HIS HIS 53 53 53 N 1 8.81 1.40 108.80 117.61 A A A ND1 CG CD2 HIS HIS HIS 60 60 60 N 1 5.60 0.70 120.80 126.40 A A A CB CG CD2 PHE PHE PHE 83 83 83 N 1 -14.02 0.70 120.80 106.78 A A A CB CG CD1 PHE PHE PHE 83 83 83 N 2 8.55 1.40 108.80 117.35 A A A ND1 CG CD2 HIS HIS HIS 53 53 53 N 2 9.65 1.40 108.80 118.45 A A A ND1 CG CD2 HIS HIS HIS 60 60 60 N 3 9.09 1.40 108.80 117.89 A A A ND1 CG CD2 HIS HIS HIS 53 53 53 N 3 -8.97 1.30 121.40 112.43 A A A CB CG ND1 HIS HIS HIS 60 60 60 N 3 -3.77 0.50 120.30 116.53 A A A NE CZ NH2 ARG ARG ARG 86 86 86 N 4 8.78 1.40 108.80 117.58 A A A ND1 CG CD2 HIS HIS HIS 53 53 53 N 5 8.60 1.40 108.80 117.40 A A A ND1 CG CD2 HIS HIS HIS 53 53 53 N 5 -9.36 1.30 121.40 112.04 A A A CB CG ND1 HIS HIS HIS 53 53 53 N 5 -7.88 1.30 121.40 113.52 A A A CB CG ND1 HIS HIS HIS 60 60 60 N 5 6.13 0.70 120.80 126.93 A A A CB CG CD2 PHE PHE PHE 83 83 83 N 5 -14.20 0.70 120.80 106.60 A A A CB CG CD1 PHE PHE PHE 83 83 83 N 6 9.81 1.40 108.80 118.61 A A A ND1 CG CD2 HIS HIS HIS 53 53 53 N 6 -7.98 1.30 121.40 113.42 A A A CB CG ND1 HIS HIS HIS 53 53 53 N 6 8.76 1.40 108.80 117.56 A A A ND1 CG CD2 HIS HIS HIS 60 60 60 N 7 8.44 1.40 108.80 117.24 A A A ND1 CG CD2 HIS HIS HIS 53 53 53 N 7 8.78 1.40 108.80 117.58 A A A ND1 CG CD2 HIS HIS HIS 60 60 60 N 8 9.46 1.40 108.80 118.26 A A A ND1 CG CD2 HIS HIS HIS 53 53 53 N 8 -8.71 1.40 123.60 114.89 A A A CD NE CZ ARG ARG ARG 86 86 86 N 8 6.22 0.50 120.30 126.52 A A A NE CZ NH1 ARG ARG ARG 86 86 86 N 9 -8.13 1.30 121.40 113.27 A A A CB CG ND1 HIS HIS HIS 53 53 53 N 9 9.17 1.40 108.80 117.97 A A A ND1 CG CD2 HIS HIS HIS 60 60 60 N 10 8.54 1.40 108.80 117.34 A A A ND1 CG CD2 HIS HIS HIS 53 53 53 N 10 8.80 1.40 108.80 117.60 A A A ND1 CG CD2 HIS HIS HIS 60 60 60 N 10 6.28 0.70 120.80 127.08 A A A CB CG CD2 PHE PHE PHE 83 83 83 N 10 -16.15 0.70 120.80 104.65 A A A CB CG CD1 PHE PHE PHE 83 83 83 N 10 -3.68 0.50 120.30 116.62 A A A NE CZ NH2 ARG ARG ARG 86 86 86 N 11 9.12 1.40 108.80 117.92 A A A ND1 CG CD2 HIS HIS HIS 60 60 60 N 11 4.81 0.70 120.80 125.61 A A A CB CG CD2 PHE PHE PHE 83 83 83 N 11 -14.01 0.70 120.80 106.79 A A A CB CG CD1 PHE PHE PHE 83 83 83 N 12 -13.72 0.70 120.80 107.08 A A A CB CG CD1 PHE PHE PHE 83 83 83 N 13 -5.55 0.90 118.30 112.75 A A A CB CG OD2 ASP ASP ASP 46 46 46 N 13 -6.86 1.10 119.40 112.54 A A A NH1 CZ NH2 ARG ARG ARG 86 86 86 N 13 3.51 0.50 120.30 123.81 A A A NE CZ NH1 ARG ARG ARG 86 86 86 N 13 3.26 0.50 120.30 123.56 A A A NE CZ NH2 ARG ARG ARG 86 86 86 N 1 A A CB CG PHE PHE 83 83 -0.113 0.017 1.509 1.396 N 1 A A CG CD1 PHE PHE 83 83 -0.168 0.015 1.383 1.215 N 2 A A CG ND1 HIS HIS 53 53 -0.094 0.015 1.369 1.275 N 2 A A CG ND1 HIS HIS 60 60 -0.094 0.015 1.369 1.275 N 3 A A CG ND1 HIS HIS 53 53 -0.123 0.015 1.369 1.246 N 3 A A CG ND1 HIS HIS 60 60 -0.099 0.015 1.369 1.270 N 4 A A CG ND1 HIS HIS 53 53 -0.096 0.015 1.369 1.273 N 4 A A CG ND1 HIS HIS 60 60 -0.114 0.015 1.369 1.255 N 5 A A CG ND1 HIS HIS 60 60 -0.097 0.015 1.369 1.272 N 5 A A CG CD1 PHE PHE 83 83 -0.171 0.015 1.383 1.212 N 6 A A CG ND1 HIS HIS 53 53 -0.103 0.015 1.369 1.266 N 6 A A CG ND1 HIS HIS 60 60 -0.096 0.015 1.369 1.273 N 7 A A CG ND1 HIS HIS 53 53 -0.103 0.015 1.369 1.266 N 7 A A CG ND1 HIS HIS 60 60 -0.100 0.015 1.369 1.269 N 7 A A CD OE2 GLU GLU 82 82 -0.070 0.011 1.252 1.182 N 8 A A CG ND1 HIS HIS 53 53 -0.098 0.015 1.369 1.271 N 8 A A CG ND1 HIS HIS 60 60 -0.105 0.015 1.369 1.264 N 9 A A CG ND1 HIS HIS 53 53 -0.107 0.015 1.369 1.262 N 10 A A CG ND1 HIS HIS 53 53 -0.099 0.015 1.369 1.270 N 10 A A CB CG PHE PHE 83 83 -0.133 0.017 1.509 1.376 N 10 A A CG CD1 PHE PHE 83 83 -0.227 0.015 1.383 1.156 N 11 A A N CA GLY GLY 47 47 -0.100 0.015 1.456 1.356 N 11 A A CG ND1 HIS HIS 53 53 -0.105 0.015 1.369 1.264 N 11 A A CG ND1 HIS HIS 60 60 -0.112 0.015 1.369 1.257 N 11 A A CB CG PHE PHE 83 83 -0.125 0.017 1.509 1.384 N 11 A A CG CD1 PHE PHE 83 83 -0.191 0.015 1.383 1.192 N 12 A A CG ND1 HIS HIS 53 53 -0.093 0.015 1.369 1.276 N 12 A A CG ND1 HIS HIS 60 60 -0.091 0.015 1.369 1.278 N 12 A A CG CD1 PHE PHE 83 83 -0.189 0.015 1.383 1.194 N 13 A A CG ND1 HIS HIS 53 53 -0.093 0.015 1.369 1.276 N 13 A A NE CZ ARG ARG 86 86 -0.107 0.013 1.326 1.219 N 1 A GLN 49 46.53 7.05 1 A HIS 53 9.25 91.99 1 A GLN 58 46.83 26.86 1 A LYS 62 -90.00 -141.60 1 A ILE 65 -88.76 30.08 1 A ASP 67 73.81 137.21 1 A TYR 68 -78.25 -165.16 1 A GLU 77 -155.03 -146.31 2 A ASP 48 -97.15 52.56 2 A CYS 50 -143.22 19.88 2 A HIS 53 51.29 90.33 2 A GLN 58 49.73 29.20 2 A TYR 68 -77.40 -166.19 2 A CYS 81 86.48 18.67 2 A THR 85 43.87 19.95 3 A ASP 48 -110.64 58.73 3 A HIS 53 10.61 92.63 3 A CYS 81 82.51 17.44 4 A HIS 53 -173.12 96.67 4 A LYS 62 -123.30 -144.35 4 A ASP 67 -176.58 141.14 5 A HIS 53 -172.30 94.48 5 A GLU 77 -155.84 -146.72 5 A THR 85 37.14 28.55 6 A GLN 49 42.21 6.78 6 A HIS 53 44.48 84.20 6 A ILE 65 36.27 36.49 6 A ASP 67 67.57 116.78 6 A TYR 68 -76.70 -169.90 6 A THR 85 40.03 20.87 7 A HIS 53 13.98 88.47 7 A THR 85 46.10 22.95 8 A GLN 49 43.29 4.91 8 A CYS 50 -112.53 54.97 8 A GLU 51 -40.61 163.93 8 A HIS 53 -174.26 93.03 8 A LYS 62 -103.29 -132.75 8 A THR 85 44.29 16.15 9 A ASP 48 -166.43 29.73 9 A CYS 50 -163.87 14.32 9 A HIS 53 39.65 91.50 9 A ASP 63 63.22 146.28 9 A ALA 73 115.88 162.28 9 A CYS 81 94.10 26.94 9 A THR 85 47.54 5.33 10 A ASP 48 -119.44 66.67 10 A CYS 50 -145.23 -22.75 10 A HIS 53 44.30 82.18 10 A ASP 67 68.08 153.51 10 A GLU 77 -143.20 -145.86 10 A THR 85 -178.29 -49.08 11 A ASP 46 -100.20 -65.56 11 A HIS 53 50.52 86.13 11 A TYR 68 -78.56 -164.71 11 A GLU 77 -154.73 -151.95 12 A GLN 49 41.99 6.58 12 A HIS 53 48.08 90.74 12 A GLU 74 -50.62 109.85 12 A GLU 77 -157.15 -145.52 13 A ASP 48 -96.09 39.26 13 A CYS 50 -154.69 23.07 13 A HIS 53 49.84 83.12 13 A ASP 67 73.13 134.62 13 A ALA 73 119.75 165.29 13 A CYS 81 92.18 27.25 EGF-LIKE MODULE OF BLOOD COAGULATION FACTOR X (N-TERMINAL, APO FORM) (NMR, 13 STRUCTURES) THREE-DIMENSIONAL STRUCTURE OF THE APO FORM OF THE N-TERMINAL EGF-LIKE MODULE OF BLOOD COAGULATION FACTOR X AS DETERMINED BY NMR SPECTROSCOPY AND SIMULATED FOLDING 1 Y N 2 N N disulf 2.383 A CYS 50 A SG CYS 6 1_555 A CYS 61 A SG CYS 17 1_555 disulf 2.379 A CYS 55 A SG CYS 11 1_555 A CYS 70 A SG CYS 26 1_555 disulf 2.501 A CYS 72 A SG CYS 28 1_555 A CYS 81 A SG CYS 37 1_555 covale 1.458 A ASP 63 A CB ASP 19 1_555 A OH 87 B O OH 1_555 COAGULATION FACTOR COAGULATION FACTOR FA10_BOVIN UNP 1 1 P00743 MAGLLHLVLLSTALGGLLRPAGSVFLPRDQAHRVLQRARRANSFLEEVKQGNLERECLEEACSLEEAREVFEDAEQTDEF WSKYKDGDQCEGHPCLNQGHCKDGIGDYTCTCAEGFEGKNCEFSTREICSLDNGGCDQFCREERSEVRCSCAHGYVLGDD SKSCVSTERFPCGKFTQGRSRRWAIHTSEDALDASELEHYDPADLSPTESSLDLLGLNRTEPSAGEDGSQVVRIVGGRDC AEGECPWQALLVNEENEGFCGGTILNEFYVLTAAHCLHQAKRFTVRVGDRNTEQEEGNEMAHEVEMTVKHSRFVKETYDF DIAVLRLKTPIRFRRNVAPACLPEKDWAEATLMTQKTGIVSGFGRTHEKGRLSSTLKMLEVPYVDRSTCKLSSSFTITPN MFCAGYDTQPEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKFGVYTKVSNFLKWIDKIMKARAGAAGSRGHSEA PATWTVPPPLPL 85 126 1APO 45 86 P00743 A 1 1 42 2 2 anti-parallel anti-parallel A GLY 59 A GLY 15 A ASP 63 A ASP 19 A TYR 68 A TYR 24 A CYS 72 A CYS 28 A PHE 76 A PHE 32 A GLU 77 A GLU 33 A PHE 83 A PHE 39 A SER 84 A SER 40 BINDING SITE FOR RESIDUE OH A 87 Software 2 A ASP 63 A ASP 19 2 1_555 A GLY 64 A GLY 20 2 1_555 1 P 1